Molecular Diagnostics Are Leading the Way to Personalized, Precision Medicine, Says Society for Women’s Health Research
Campaign to Highlight These Important Innovations in Women’s Health Launched at SWHR 2014 Gala
Article ID: 616205
Released: 8-Apr-2014 9:30 AM EDT
Source Newsroom: Society for Women's Health Research (SWHR)
Newswise — The Society for Women’s Health Research (SWHR®), the leading voice on research into the biological sex differences between women and men, is proud to announce a public awareness campaign focused on “Transforming Science: Innovations in Molecular Diagnostics.” SWHR launched the yearlong focus on this rapidly advancing field in women’s health during the 2014 Annual Gala on April 2. More details at SWHR.org.
Diagnostics are an important part of every stage of health care, with 70 percent of medical decision-making influenced by these tests. Molecular diagnostics detect specific genetic sequences and proteins to help diagnose and monitor disease, assess risk for disease, and decide which treatments work best for individual patients.
At the gala, SWHR premiered an 8 ½-minute film highlighting the powerful impact of molecular diagnostics on women’s health, including coronary artery disease, breast cancer, ovarian cancer, colorectal cancer, sexually transmitted diseases, and mental health. This will be the cornerstone of a national multimedia campaign that will include print, TV and radio public service announcements that highlight the benefits of molecular diagnostics for everyday women.
SWHR also will focus on the impact of molecular diagnostics at a series of events this year before the medical community, health care advocates and policymakers on Capitol Hill and the administration. On May 13, SWHR will host a Congressional briefing that will feature several presentations and speakers highlighting the advances in molecular diagnostics, particularly through the patient experience.
On September 12, SWHR will host a breakfast and panel discussion on molecular diagnostics at TEDMED in Washington, D.C. TEDMED is an annual conference that brings together leading innovators and investors from the global community who share an interest in science, medicine and research. The panel of nationally recognized experts will discuss various topics related to molecular diagnostics, including the history of the field, current and future innovations, and the value of molecular diagnostics in medicine and health care.
“The Society for Women’s Health Research is the national leader in advocating for greater understanding into how diseases and conditions affect women and men differently. SWHR believes in the promise of molecular diagnostics and its ability to shape the future of health care for men and women alike,” said Phyllis Greenberger, SWHR president and CEO. “Molecular diagnostics are changing the way we diagnose and treat disease, and are helping health care professionals make individualized, more effective medical decisions for patients. These revolutionary tests are leading the way to personalized, precision medicine.”
Check out SWHR’s resource page on molecular diagnostics at SWHR.org.
The Society for Women’s Health Research (SWHR), the national thought leader in the study of sex differences in disease, is dedicated to transforming women’s health through science, advocacy and education. SWHR advocates for increased public and private funding for women’s health; greater inclusion of women and minorities in medical studies; and analysis of the biological differences between men and women in disease and health issues. For more information, visit SWHR.org.